StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report report published on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $6.00 price objective on shares of vTv Therapeutics in a research report on […]
StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a report published on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $6.00 price target on shares of vTv Therapeutics in a research note on Tuesday, March 7th. […]
StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $6.00 target price on shares of vTv Therapeutics in a research note […]
Equities researchers at StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $6.00 target price on shares of vTv Therapeutics in a research note […]
Stock analysts at StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a report issued on Monday. The firm set a “hold” rating on the biotechnology company’s stock. vTv Therapeutics Stock Performance Shares of vTv Therapeutics stock opened at $0.86 on Monday. The firm’s 50-day simple moving average is $0.82 and […]